Continuing Education Post-test

Page1 / 3
 
33% of survey complete.

To receive contact hours, please read the program in its entirety, answer the following post-test questions, and complete the program evaluation. A certificate will be awarded for a score of 80% (8 correct) or better. A certificate will be mailed within 4 to 6 weeks. There is no charge for CNE credit.

PLEASE SELECT THE BEST ANSWER

Question Title

1. Patients with multiple sclerosis (MS) who are on disease-modifying therapy (DMT) should be monitored for safety and adverse effects of therapy:

Question Title

2. A patient with MS in your practice has been prescribed a DMT, but 3 months later has not yet filled the prescription. An appropriate course of action would be:

Question Title

3. Electrocardiogram (ECG) and heart rate monitoring are part of the safety monitoring protocol for:

Question Title

4. Monthly liver function testing is recommended for patients receiving which of the following DMTs?

Question Title

5. Among patients receiving a DMT, complete blood count (CBC) is recommended:

Question Title

6. Progressive multifocal leukoencephalopathy (PML) is caused when:

Question Title

7. True or False? Leukopenia due to treatment with interferon-based DMTs has been associated with serious opportunistic infections among patients with MS.

Question Title

8. In discussing risk acceptance with a patient in regard to a new MS therapy, the MS nurse should always:

Question Title

9. Research about medication use in general shows that patients:

Question Title

10. Potential adverse effects of MS DMTs:

T